
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
Stephen Eckel, PharmD, MHA, BCPS, FASHP, describes the challenges pharmacists may face as the health care industry continues to evolve.
Stephen Eckel, PharmD, MHA, BCPS, FASHP, describes the challenges pharmacists may face as the health care industry continues to evolve.
“Obviously, drugs are costing more and more, and people are getting sick and living longer,” he says. “Yet, the dollars that we have to spend on health care are fewer and fewer.”






